The US Food and Drug Administration (FDA) has granted marketing clearance for an injectable microchip neuromodulation device for the relief of chronic back and leg pain.

The Stimwave Freedom Spinal Cord Stimulation (SCS) system is expected to be available in the United States as of January 2015, the company, Stimwave Technologies Inc, reported in a statement released December 2.

The device, which the company calls an “electroceutical” device, is already marketed throughout Europe for this indication. 

Developed by scientists and engineers led by co-inventor and company chairman Laura Tyler Perryman, the technology involves a tiny injectable microchip device that delivers small energy pulses to electrodes near surrounding nerves, the statement notes.

READ FULL ARTICLE Curated publisher From Med Scape